首页> 外文会议>Annual conference of the Veterinary Cancer Society >BIOMARKERS OF METASTASIS AND RESISTANCE TO CHEMOTHERAPY IN CANINE OSTEOSARCOMA
【24h】

BIOMARKERS OF METASTASIS AND RESISTANCE TO CHEMOTHERAPY IN CANINE OSTEOSARCOMA

机译:犬骨膜瘤中的转移和化疗抗性的生物标志物

获取原文

摘要

Osteosarcoma (OSA) is the most common bone tumor in dogs and roughly 80% of OSA tumors arise in the appendicular skeleton of large breed dogs. The majority of patients experience lung metastasis following tumor removal and chemotherapy while a minority remains disease-free for six months or longer. Consequently, the ability to characterize primary OSA for its metastatic potential and chemotherapy resistance would substantially improve the ability to prevent or treat metastatic disease.
机译:骨肉瘤(OSA)是狗中最常见的骨肿瘤,大约80%的OSA肿瘤出现在大型品种狗的附奇骨架中。大多数患者在肿瘤去除和化疗后经历肺转移,而少数群体仍然无病6个月或更长时间。因此,对其转移潜力和化疗抗性进行初生OSA的能力将大大提高预防或治疗转移性疾病的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号